Showing results (41-50 of 134) with videos related to
Sort By:
Pageof 14
American Journal of Physiology. Heart and Circulatory Physiology|January 31, 2004
Limited transfer of cytosolic NADH into mitochondria at high cardiac workloadJ Michael O'Donnell, Raymond K Kudej, Kathyrn F LaNoue, et al.American Journal of Physiology. Heart and Circulatory Physiology|March 27, 2004
Aging increases stiffness of cardiac myocytes measured by atomic force microscopy nanoindentationSamuel C Lieber, Nadine Aubry, Jayashree Pain, et al.Basic Research in Cardiology|September 10, 2017
Disruption of adenylyl cyclase type 5 mimics exercise trainingJohn J Guers, Jie Zhang, Sara C Campbell, et al.Journal of Molecular and Cellular Cardiology|February 12, 2004
Propranolol prevents enhanced stress signaling in Gs alpha cardiomyopathy: potential mechanism for beta-blockade in heart failureVijaya Karoor, Stephen F Vatner, Gen Takagi, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|March 27, 2020
Rats are protected from the stress of chronic pressure overload compared with miceKoichi Nishimura, Marko Oydanich, Jie Zhang, et al.Cardiovascular Research|January 16, 2008
Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytesCarmine Morisco, Chiara Marrone, Jonathan Galeotti, et al.American Journal of Physiology. Heart and Circulatory Physiology|October 11, 2005
Dual effects of mesenteric lymph isolated from rats with burn injury on contractile function in rat ventricular myocytesAtsuko Yatani, Da-Zhong Xu, Keiichi Irie, et al.Carcinogenesis|June 14, 2011
Caloric restriction reduces growth of mammary tumors and metastasesMariana S De Lorenzo, Erdene Baljinnyam, Dorothy E Vatner, et al.Cardiovascular Research|April 2, 2003
Characterization of pDJA1, a cardiac-specific chaperone found by genomic profiling of the post-ischemic swine heartChristophe Depre, Li Wang, James E Tomlinson, et al.Journal of Molecular and Cellular Cardiology|May 26, 2018
A novel adenylyl cyclase type 5 inhibitor that reduces myocardial infarct size even when administered after coronary artery reperfusionJie Zhang, Daniel Levy, Marko Oydanich, et al.Pageof 14